Mesenchymal stem cells (MSCs) have been considered an appropriate source for cell-based therapy over the last decade. MSCs efficacy in clinical applications has shown healing effects against several diseased ... those…
custommade tissue/organs for clinical use. This paper covers a wide range of stem cell-based tissue engineering topics, such as neuron repair, cardiac patches, skin regeneration, gene therapy ... other than stem cells…
nasal epithelial cells could not substitute for bronchial epithelial cells. The data from primary cell-based tissue models suggest that B. Pertussis can adhere to and invade both differentiated primary ... into…
built by mixing desired enzyme activities outside of cells, can obviate problems associated with cell-based methods. Yet supplanting cell-based methods of chemical production will require the creation
Accordingly, in the present review, the authors are trying to discuss stem cell-based biotechnologies as promising therapeutic options for neurological disorders secondary to COVID-19 infection through reviewing…
prosthodontics” using artificial materials such as dentures and dental implants. Recent development of stem cell-based regenerative medicine has introduced the concept of “regenerative prosthodontics” to our field…
some conditions, such as hematopoietic stem cell transplants for leukemia and epithelial stem cell-based treatments for burns and corneal disorders, the scope of potential stem cell-based therapies
Autologous cell-based tissue engineering may offer new opportunities for the treatment of long bone defects. Experimental work in small animal models requires an important up scaling to meet ... segments that need…
present study, technical objectives for this purpose are summarized. The ultimate goal of cell-based therapies is to regenerate and restore normal function. Populations of embryonic, fetal, adult stem cells ... cells…
plans, in patients suffering from chronic and recalcitrant wounds. The use of mesenchymal stem cell-based therapies is an attractive and upcoming approach for the treatment of difficult-toheal wounds ... closure. Both…
diseases can cause permanent tissue loss and disability; moreover, clinical management via cell-based regenerative therapies is limited due to the paucity of accurate molecular and genetic data. The advent…
biodistribution have severely curtailed the use of those small molecule inhibitors in cell-based assays and animal models of ricin intoxication. High-throughput, cell-based screens run in parallel
invasiveness and a high risk of degeneration. In order to regenerate damaged heart muscle, cell-based regenerative therapies and tissue engineering products have gained popularity these days. Injectable hydrogels
content of the cells, thus can improve the regenerative potential of these cells for cell-based therapeutics for various diseases. These compounds can be further developed into drugs to complement ... cell-based…
deaths reached 92,941 cases. There has been a recent update on stem cell-based biological, medical therapy as an optional treatment to handling COVID-19 due to its potential ... vitro study, it could be the basis for…
treatments. To accelerate and minimize the cost involved in drug discovery efforts, a cell-based high-content/high-throughput reverse transfection microarray screening platform will be employed to screen hundreds…
potential neuroregeneration in this clinical condition. Mesenchymal stem cells (MSCs) are ideal for cell-based therapy in various inflammatory diseases because of their immunosuppressive and tissue repair properties…
extensively used for creating functional bioengineered cardiac tissues and are considered attractive candidates for cell-based therapies. However, both in health and disease, cardiac fibroblasts present heterogeneous…
extensively used for creating functional bioengineered cardiac tissues and are considered attractive candidates for cell-based therapies. However, both in health and disease, cardiac fibroblasts present heterogeneous…
system (CNS) damage through delivery of therapeutic agents of cell regeneration. Clinical translation of cell-based therapies raises concerns about long-term stability, differentiation and fate, absence of tumorigenicity
permanent cure except for liver transplantation, and current therapies present several shortcomings. Since stem cell-based therapy offers a promising alternative for the treatment of this disorder, we evaluated
have shown them to be bioactivated by CYP1A1 and 2W1 in cell-free and cell-based assays. At the meeting we will update on novel data from our drug discovery
establish normal barrier integrity in inflammatory bowel disease are warranted, and luminal stem cell-based approaches might have an intriguing potential. Transplantation of in vitro expanded intestinal epithelial stem…